Publication | Closed Access

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Placebo-controlled Phase 2Neoadjuvant TherapyMedicinePathologyPlatinum-pretreated RecurrentHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation Oncology